— Know what they know.
Not Investment Advice
Also trades as: 0I3I.L (LSE) · $vol 0M

COO NASDAQ

The Cooper Companies, Inc.
1W: +2.5% 1M: -11.5% 3M: -26.3% YTD: -24.2% 1Y: -25.9% 3Y: -37.0% 5Y: -36.0%
$61.54
+0.09 (+0.14%)
 
Weekly Expected Move ±3.3%
$56 $58 $60 $62 $64
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Sell · Power 38 · $12.0B mcap · 194M float · 1.12% daily turnover · Short 28% of daily vol
Smart Money Score
Moderate 50
Insider+$1.3M
Congress
ETF Holdings
Key Statistics
Market Cap$12.0B
52W Range58.89-89.83
Volume1,684,292
Avg Volume2,161,651
Beta0.89
Dividend
Analyst Ratings
15 Buy 8 Hold 1 Sell
Consensus Buy
Company Info
CEOAlbert G. White
Employees16,000
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1983-01-21
6101 Bollinger Canyon Road
San Ramon, CA 94583
US
925 460 3600
About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Recent Insider Trades

NameTypeSharesPriceDate
Rosebrough Walter M M-Exempt 832 2026-04-01
Rosebrough Walter M M-Exempt 832 2026-04-01
WEISS ROBERT S M-Exempt 3,654 2026-04-01
WEISS ROBERT S A-Award 3,779 2026-04-01
WEISS ROBERT S M-Exempt 3,654 2026-04-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms